{"id":49788,"date":"2022-10-19T12:02:09","date_gmt":"2022-10-19T10:02:09","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/"},"modified":"2022-10-19T12:02:09","modified_gmt":"2022-10-19T10:02:09","slug":"prodigy-care-services-announces-its-prodigyrx-clinical-panel","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/","title":{"rendered":"Prodigy Care Services Announces its ProdigyRx Clinical Panel"},"content":{"rendered":"
\n

AUSTIN, Texas–(BUSINESS WIRE)–#clinicalpanel<\/a>–Prodigy Care Services has formed a clinical panel to provide insight and guidance to its workers\u2019 compensation pharmacy benefits manager, ProdigyRx.\n<\/p>\n

<\/a><\/p>\n

\nThe panel brings expertise in a wide range of pharmacy management areas to support ProdigyRx\u2019s clinical programs, evaluate emerging therapies, and consult on extremely complex cases. Initial members are Maud Boateng, Pharm.D., MBA, M.S., P.A.C.S., P.M.P.; A. J. Day, Pharm.D.; Phuoc Anne Nguyen, Pharm.D., M.S., B.C.P.S.; Nicole Olson, Pharm.D., B.C.A.C.P.; and Eddu Oparie-Addoh, Pharm.D., B.C.P.S., B.C.C.C.P.\n<\/p>\n

\n\u201cOur clinical panelists are accomplished Pharm.Ds, thought leaders and practicing clinical professionals who understand the clinical needs of patients in various practice specialties,\u201d said Prodigy CEO and Co-founder Del Doherty, Pharm.D., Ph.D., MBA.\n<\/p>\n

\nFor example, Dr. Boateng has a strong background in specialty pharmacy and has worked in the infusion, hospital and retail pharmacy industries. Her eclectic educational background combines a Pharm.D with a leadership emphasis, a master\u2019s in Clinical Research and an MBA with a focus on health care administration and human resources.\n<\/p>\n

\nVice President of Clinical Services at PCCA<\/a>, Dr. Day has over 15 years\u2019 experience in clinical and compounding pharmacy. He has been heavily involved in regulatory issues, working with the FDA and several state boards of pharmacy to review pharmacy policies regarding patient access and quality control. Dr. Day has also published nine articles in seven journals on clinical topics.\n<\/p>\n

\nDr. Nguyen has over a decade of health system experience, focused on population health, pharmacy operations, clinical services, and healthcare leadership. A CDC Fellow in Population Health, Dr. Nguyen serves on the faculty of the University of Houston College of Pharmacy. Working in in-patient hospital settings for most of her career, she is a board-certified pharmacotherapy specialist. Dr. Nguyen is also a medical writer and a career and leadership coach.\n<\/p>\n

\nA board-certified ambulatory care pharmacist, Dr. Olson performs comprehensive medication reviews and manages chronic disease states by optimizing patients\u2019 medications. She has more than 10 years of clinical pharmacy practice experience, mainly in cardiology.\n<\/p>\n

\nDr. Oparie-Addoh has served as a pharmacist in hospital settings for more than 10 years and is currently with the University of Wisconsin Hospital and Clinics in Madison, Wisconsin. He provides pharmacotherapy services to manage acute and chronic conditions, specifically trauma and critical care, internal medicine, surgery, and nutrition support. He holds the Certified Nutrition Support Clinician credential and is a board-certified pharmacotherapy specialist.\n<\/p>\n

\n\u201cWe are proud to have clinical advisors with such deep expertise in diverse areas as we grow as a patient-focused PBM,\u201d said Prodigy President Matt Imes.\n<\/p>\n

\nAbout Prodigy Care Services<\/b>\n<\/p>\n

\nBased in Austin, Texas, Prodigy Care Services was founded in 2020 to bring pharmacy transparency and control to workers\u2019 compensation insurers, third-party administrators, and self-insured\/administered employers across the United States. <\/i>Pass-through pricing, proactive clinical controls, and a suite of evidence-based, patient-centric clinical programs and tools are among its offerings. For more information, please see https:\/\/prodigyrx.com\/<\/a> or call (713) 322-6667.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nHelen King Patterson, King Knight Communications, 813-690-4787, helen@kingknight.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

AUSTIN, Texas–(BUSINESS WIRE)–#clinicalpanel–Prodigy Care Services has formed a clinical panel to provide insight and guidance to its workers\u2019 compensation pharmacy benefits manager, ProdigyRx. The panel brings expertise in a wide range of pharmacy management areas to support ProdigyRx\u2019s clinical programs, evaluate emerging therapies, and consult on extremely complex cases. Initial members are Maud Boateng, Pharm.D., … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49788","6":"format-standard","7":"category-industry"},"yoast_head":"\nProdigy Care Services Announces its ProdigyRx Clinical Panel - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prodigy Care Services Announces its ProdigyRx Clinical Panel - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"AUSTIN, Texas–(BUSINESS WIRE)–#clinicalpanel–Prodigy Care Services has formed a clinical panel to provide insight and guidance to its workers\u2019 compensation pharmacy benefits manager, ProdigyRx. The panel brings expertise in a wide range of pharmacy management areas to support ProdigyRx\u2019s clinical programs, evaluate emerging therapies, and consult on extremely complex cases. Initial members are Maud Boateng, Pharm.D., ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-19T10:02:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221019005210\/en\/1595072\/21\/Prodigylogo_white_background.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Prodigy Care Services Announces its ProdigyRx Clinical Panel\",\"datePublished\":\"2022-10-19T10:02:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\\\/\"},\"wordCount\":533,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221019005210\\\/en\\\/1595072\\\/21\\\/Prodigylogo_white_background.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\\\/\",\"name\":\"Prodigy Care Services Announces its ProdigyRx Clinical Panel - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221019005210\\\/en\\\/1595072\\\/21\\\/Prodigylogo_white_background.jpg\",\"datePublished\":\"2022-10-19T10:02:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221019005210\\\/en\\\/1595072\\\/21\\\/Prodigylogo_white_background.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221019005210\\\/en\\\/1595072\\\/21\\\/Prodigylogo_white_background.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prodigy Care Services Announces its ProdigyRx Clinical Panel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prodigy Care Services Announces its ProdigyRx Clinical Panel - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/","og_locale":"en_US","og_type":"article","og_title":"Prodigy Care Services Announces its ProdigyRx Clinical Panel - Pharma Trend","og_description":"AUSTIN, Texas–(BUSINESS WIRE)–#clinicalpanel–Prodigy Care Services has formed a clinical panel to provide insight and guidance to its workers\u2019 compensation pharmacy benefits manager, ProdigyRx. The panel brings expertise in a wide range of pharmacy management areas to support ProdigyRx\u2019s clinical programs, evaluate emerging therapies, and consult on extremely complex cases. Initial members are Maud Boateng, Pharm.D., ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-19T10:02:09+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221019005210\/en\/1595072\/21\/Prodigylogo_white_background.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Prodigy Care Services Announces its ProdigyRx Clinical Panel","datePublished":"2022-10-19T10:02:09+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/"},"wordCount":533,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221019005210\/en\/1595072\/21\/Prodigylogo_white_background.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/","url":"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/","name":"Prodigy Care Services Announces its ProdigyRx Clinical Panel - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221019005210\/en\/1595072\/21\/Prodigylogo_white_background.jpg","datePublished":"2022-10-19T10:02:09+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221019005210\/en\/1595072\/21\/Prodigylogo_white_background.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221019005210\/en\/1595072\/21\/Prodigylogo_white_background.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/prodigy-care-services-announces-its-prodigyrx-clinical-panel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Prodigy Care Services Announces its ProdigyRx Clinical Panel"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49788","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49788"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49788\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49788"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49788"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49788"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}